These findings suggest that omalizumab reduced airway wall thickness and airway inflammation. Larger patient studies with longer-term follow-up are needed to show whether omalizumab can truly maintain improved airway wall dimensions.
No takes yet. Share an insight, caveat, or question.
Hoshino et al. (2012) studied this question.